Canadian Adaltis Aquires Diagnostics Distributor in China
Adaltis Inc., a Montreal-based international diagnostic company, is pleased to announce the acquisition of DCH Healthcare Products Ltd. from CITIC Pacific Ltd. DCH Healthcare Products Ltd. is an important healthcare diagnostics distributor with extensive operations in mainland China and Hong Kong. DCH Healthcare will become Adaltis' commercial platform in the Asian region and will contribute greatly in growing Adaltis market share in this region.
Mr. Pierre Larochelle, President and Chief Executive Officer of Adaltis Inc. said "This transaction is an important step towards our objective of building a strong commercial presence in China and South-East Asia. We are very pleased to have completed this transaction with CITIC Pacific, our partner with whom we have established a joint venture for the manufacturing of our in-vitro diagnostic products."
"Adaltis is proceeding efficiently with its plan to grow in key emerging Asian markets. With the acquisition of DCH Healthcare Products, we will now have our most significant global sales force on the ground in China and Hong Kong, selling Adaltis products. Through our sales force in China and Hong Kong, we will be able to accelerate further in China the commercial launch of our new diagnostic system, Eclectica, as well as to enhance further the value of our important infectious disease product platform" said Mr. Larochelle.
Other news from the department business & finance
